Revolution Medicines

Revolution Medicines (NASDAQ:RVM) is a clinical-stage precision oncology company focused on developing novel targeted therapies to inhibit elusive, frontier targets within notorious growth and survival pathways, with particular emphasis on the RAS signaling pathway.